Department of Gastrointestinal and Hepato-Biliary-Pancreatic Surgery, Nippon Medical School, 1-1-5 Sendagi, Bunkyo-ku, Tokyo, 113-8603, Japan.
Department of Gastroenterological Surgery, Graduate School of Medical Sciences, Kumamoto University, 1-1-1 Honjo, Chuou-Ku, Kumamoto, 860-8556, Japan.
Int J Colorectal Dis. 2023 Mar 3;38(1):58. doi: 10.1007/s00384-023-04360-6.
Extended colectomy is sometimes chosen for treatment of transverse colon cancer (TCC) because of concerns about short- and long-term outcomes. However, there is still a lack of evidence regarding the optimal surgical procedure.
We retrospectively collected and analyzed data of patients who underwent surgical treatment of pathological stage II/III TCC at four hospitals from January 2011 to June 2019. We excluded the patients with TCC located at distal transverse colon, and just evaluated and analyzed proximal and middle third TCC. Inverse probability treatment-weighted propensity score analyses was used to compare short- and long-term outcomes between patients who underwent segmental transverse colectomy (STC) and those who underwent right hemicolectomy (RHC).
In total, 106 patients were enrolled in this study (STC group, n = 45; RHC group, n = 61). The patients' backgrounds were well balanced after matching. The incidence of major postoperative complications (Clavien-Dindo grade ≥ III) was not significantly different between the STC and RHC groups (4.5% vs. 5.6%, respectively; P = 0.53). The 3-year recurrence-free survival and overall survival rates were not significantly different between the STC and RHC groups (88.2% vs. 81.8%, P = 0.86 and 90.3% vs. 91.9%, P = 0.79, respectively).
RHC has no significant benefits over STC with respect to either short- or long-term outcomes. STC with necessary lymphadenectomy could be an optimal procedure for proximal and middle TCC.
由于对短期和长期结果的担忧,有时会选择扩大结肠切除术来治疗横结肠癌(TCC)。然而,关于最佳手术方法仍缺乏证据。
我们回顾性地收集并分析了 2011 年 1 月至 2019 年 6 月在四家医院接受手术治疗病理分期 II/III 期 TCC 的患者数据。我们排除了位于横结肠远端的 TCC 患者,仅评估和分析了近端和中段 TCC。采用逆概率治疗加权倾向评分分析比较接受节段性横结肠切除术(STC)和右半结肠切除术(RHC)的患者的短期和长期结果。
本研究共纳入 106 例患者(STC 组,n=45;RHC 组,n=61)。匹配后患者背景均衡。STC 组和 RHC 组的主要术后并发症(Clavien-Dindo 分级≥III)发生率无显著差异(分别为 4.5%和 5.6%;P=0.53)。STC 组和 RHC 组的 3 年无复发生存率和总生存率无显著差异(88.2%比 81.8%,P=0.86 和 90.3%比 91.9%,P=0.79)。
在短期和长期结果方面,RHC 并没有比 STC 有显著优势。对于近端和中段 TCC,进行必要的淋巴结清扫的 STC 可能是一种最佳手术方式。